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Background: Rupture of infected anastomotic femoral artery pseudoaneurysms (AFAPs) represents a limb and life-
threatening condition requiring emergency intervention. This study aimed to evaluate the feasibility, safety, and efficacy
of a hybrid repair for ruptured infected AFAPs consisted of percutaneous stent-graft deployment and second-stage
surgical debridement.
Methods: Between October 2004 and January 2008, 6 patients (3 female, mean age 65.8  11.4 years) with ruptured
infected AFAPs were treated with emergent percutaneous stent-graft implantation and secondary surgical debridement.
Three patients had undergone a femoro-popliteal and 1 a femoro-tibial bypass for peripheral arterial disease, while 2
patients had a femoral arteriovenous graft (AVG) for hemodialysis access due to chronic renal failure. Four pseudoan-
eurysms were located at the common femoral artery (CFA) and 2 involved the superficial femoral artery (SFA). Mean
pseudoaneurysm diameter was 6.8  0.9 mm (range, 5.4-7.8 mm). The mean interval between the initial operation and
presentation to our department was 26.7  14.5 months (range, 7-50 months). All patients suffered from severe
comorbidities and were judged unfit for major surgery under general anesthesia.
Results: All patients were successfully managed by urgent percutaneous deployment of covered stents at the site of the
arterial deficit. Extensive surgical debridement along with pseudoaneurysm excision was accomplished successfully in all
6 patients 1-3 days after stent-graft placement under local anesthesia, without the need for extended vessel exposure for
proximal and distal control. No death occurred within 30 days after stent-graft implantation. During follow-up, (mean
14.1 8.2 months, range, 6 to 25months) all stent-grafts remained patent without endoleak, while no signs of recurrent
local or systemic infection were noticed. Two patients died at 8 and 10 months after the procedure due to heart failure
complications and acute myocardial infarction, respectively.
Conclusion: Emergency stent-graft deployment, followed by secondary surgical debridement and long-term antimicrobial
therapy is a viable alternative for ruptured infected AFAPs. Especially for patients unfit for major surgery, it may be the
most favorable treatment option. (J Vasc Surg 2009;49:938-45.)Anastomotic pseudoaneurysms result from suture
line interruption between the graft material and the
native vessel. Although all anastomotic sites may be
involved, the femoral artery is far more vulnerable with
an incidence ranging from 0.5% to 23.7%.1,2
Rupture of anastomotic femoral artery pseudoaneu-
rysms (AFAPs) represents a limb and life threatening con-
dition that occurs most commonly in the presence of
infection and requires emergency intervention.1 Tradi-
tional management consists of open surgery with aneurysm
excision and arterial flow restoration. However, this ap-
proach has a mortality rate up to 20% in cases of infection2
that is even higher in emergency arterial reconstructions
due to rupture.3
Endovascular therapy with stent-grafts, although ex-
tensively applied in several vascular diseases, has been
scarcely documented in the treatment of ruptured infected
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938anastomotic pseudoaneurysms.4,5 However, such a treat-
ment may be advantageous especially in surgical high-risk
patients requiring urgent intervention. Due to its minimally
invasive nature, it may reduce operative risk, while it may
also be more prompt than surgery, which requires extensive
time-consuming vessel exposure in previously operated
fields with distorted anatomy. Nevertheless, there is an
obvious concern that stent-graft exclusion rather than sur-
gical excision of the pathology may lead to closed-spaced
infection and contamination of the newly placed endopros-
thesis with possible devastating results.6
In this study, we present our experience with a hybrid
procedure including emergent AFAP exclusion with a
stent-graft followed by secondary pseudoaneurysm exci-
sion and surgical debridement in a group of patients that
presented with ruptured infected AFAPs requiring emer-
gency treatment but were unfit for major surgery under
general anesthesia due to severe comorbidities.
MATERIALS AND METHODS
Between October 2004 and January 2008, 6 patients
with ruptured infected AFAPs were treated with percuta-
neous stent-graft implantation and subsequent surgical de-
bridement in our department. Their medical records were
retrospectively analyzed for this study.
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were subjected to color duplex ultrasound scan study,
which confirmed the presence of a femoral pseudoaneu-
rysm. In addition, patients with a large inguinal mass ex-
tending higher to the inguinal ligament were also subjected
to contrast-enhanced computed tomography (CT) scan of
the lower abdomen and upper thigh to obtain further
details about the morphology and extension of the pseudo-
aneurysm and the involvement of the surrounding retro-
peritoneal structures. Finally, patients were put on i.v.
broad-spectrum antibiotics after blood and, whenever pos-
sible, wound cultures were drawn.
Patients were operated on as soon as possible after the
completion of their evaluation. Informed consent was ob-
tained from each patient after the nature of the procedure
had been fully explained.
Procedure. The procedures were performed in the
endovascular suite under local anesthesia. The patients
were monitored with pulse oximetry, electrocardiogram
(ECG), and blood pressure. In 5 patients, a contralateral
femoral approach was used, with an 8F or 10F, 45 cm long
introducer sheath (Arrow International Inc, Reading, Pa),
depending on the intended stent-graft type and diameter.
In 1 patient that had a thrombosed femoral arteriovenous
graft (AVG) for renal dialysis, the procedure was accom-
plished through an ipsilateral retrograde popliteal approach
using a 7F introducer sheath.
After sheath insertion, 5000 IU of heparin were admin-
istered intravenously (i.v.). Once the tip of the introducer
sheath was well positioned in the external iliac artery, a
preliminary angiogram was performed to obtain anatomic
details of the pseudoaneurysm. Subsequently a 0.018
“steerable guidewire was advanced carefully in the superfi-
cial femoral artery (SFA), while in patients that the AFAP
was located in close proximity to the femoral bifurcation
(within 1.5 cm either distal or proximal to the bifurcation)
a second 0.014” stearable guidewire was carefully placed in
the pseudoaneurysm sac that was then exchanged for a 4F
angled multipurpose catheter in order to maintain access
for coil deployment in cases of incomplete pseudoaneurysm
exclusion after stent-graft placement. In 2 patients that the
working length at the SFA was not sufficient due to native
occlusion of the SFA, the guidewire was advanced in
the profunda femoral artery. Either self- or balloon-
expandable stent-grafts were then deployed at the appro-
priate position covering the pseudoaneurysm neck. Extra
attention was given to avoid sacrificing the profunda fem-
oral artery. Gentle post-dilation of self-expanding stent-
grafts with an appropriate size balloon-catheter was per-
formed routinely in order to achieve better sealing.
Completion angiogram was then performed to confirm
proper stent-graft position and exclusion of the pseudoan-
eurysm as well as patency of the femoral arteries. Finally,
hemostasis was achieved by manual compression alone at
the contralateral femoral puncture site.
One to 3 days following stent-graft placement, patients
underwent surgical debridement of the original groin
wound under local anesthesia. Since the arterial deficit wasalready covered with the stent-graft, there was no need for
proximal and distal vessel control that would probably
require a retroperitoneal exposure of the external iliac
artery and a more extended exposure of the SFA. Extensive
debridement of the suppurative surgical field was per-
formed; the groin mass was incised and all necrotic material
was excised. The pseudoaneurysm sac was opened and the
wall tissue was removed, the cavity was then copiously
irrigated with saline. Additionally, the occluded grafts were
completely removed. In cases that the arterial defect and
the underlying stent-graft were exposed during debride-
ment surgery, the sartorius muscle was utilized as a flap to
cover the common femoral artery (CFA) and protect the
stent-graft from infection. Wound edges were finally ap-
proximated with interrupted nylon sutures.
All patients were discharged on life-long oral antiplate-
let treatment (clopidogrel 75 mg daily) and case-specific
oral long-term suppressive antibiotic therapy according to
the clinical and laboratory parameters of the infection.
Patients were followed-up with clinical examination,
leukocyte count, C-reactive protein measurement, and du-
plex ultrasound scan at 1, 3, and 6 months, and biannually
thereafter. Remained stent-graft patency and absence of
infection or blood extravasation were themain points of the
clinical and imaging follow-up.
Statistical analysis was performed with the SPSS for
Windows (v 10.0, Chicago, Ill). Continuous data are pre-
sented as mean  standard deviation (SD).
RESULTS
Patient demographic characteristics are summarized in
the Table. Three patients were female. Mean age was 65.8
11.4 years (range, 48-79 years). Three patients had under-
gone a femoro-popliteal and 1 patient had a femoro-tibial
bypass for peripheral arterial disease, while 2 patients had
femoral AVGs for hemodialysis access due to chronic renal
failure, which are markedly more prone to infection com-
pared to infrainguinal bypass conduits. All grafts were
already occluded before presentation to our department.
Two patients had ipsilateral above the knee amputation.
The mean interval between the initial operation and pre-
sentation to our department was 26.7  14.5 months
(range, 7-50 months).
One patient suffered from pseudoaneurysm-free rup-
ture and was admitted with a bleeding pulsatile right groin
mass and concomitant seropurulent drainage, while an-
other one had intermittent bleeding with three episodes of
hemorrhage before admission to our department. The re-
maining 4 patients had contained rupture and presented
with a pulsatile groin mass and overlying ecchymosis (Fig
1). Additionally, all 6 patients had clinically-evident infec-
tion. Five patients were febrile on admission, while all 6
patients had increased white blood cell count (mean 15.1
3.1  109/L, range, 12-20  109/L).
One patient already had a CT-angiography prior to
presentation to our department. Four patients underwent
color duplex ultrasonography scan preoperatively that con-
firmed the presence of a pseudoaneurysm. Two of these
F, con
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additionally subjected to lower abdomen and upper thigh
contrast-enhanced CT scans in order to assess the extension
of the infection at the retroperitoneal tissues. Finally, the
patient that presented with a bleeding groin mass due to
AFAP-free rupture was transferred immediately to the en-
dovascular suite without preoperative imaging studies.
Three pseudoaneurysms were located at the proximal
or mid portion of the CFA (1 right, 2 left side), one
involved the distal part of the right CFA in close proximity
to the femoral bifurcation and the remaining two involved
the SFA (1 right, 1 left side). Mean pseudoaneurysm diam-
eter was 6.8  0.9cm (range, 5.4-7.8 cm).
All 6 patients were classified as ASA 4, according to the
American Society of Anesthesiologist physical status scale.
All patients were considered unfit for open surgery under
general anesthesia due to severe comorbidities and poor
general condition (Table) and were managed by deploy-
ment of covered stents at the site of the arterial deficit. In 3
patients, the stent-graft was deployed at the CFA and in 2 at
the SFA. In one case that there was flush SFA occlusion, the
stent-graft was deployed in the CFA with its distal end
extending into the profunda femoral artery (PFA).
Stent-graft placement was technically successful in all
cases (Fig 2). In 1 patient, two stent-grafts were used for a
total of seven stent-grafts in 6 patients. In 4 cases, self-
expanding stent-grafts were used (Viabahn, W.L. Gore &
Associates, Flagstaff, Ariz), while in 2 cases balloon-
expandable covered stents were placed (Advanta V12,
AtriumMedical Corp, Hudson, NH). Upon completion of
the procedure, complete exclusion of the anastomotic an-
eurysmwas identified through angiogram in all except for 1
patient. The latter was the aforementioned patient with a
large pseudoaneurysm (7.8 cm in diameter) at the distal
CFA, about 1 cm proximal to the femoral bifurcation. The
SFA was patent, since this patient did not suffer from
peripheral arterial disease (PAD), but had a femoral AVG.
This anatomy made stent-graft placement challenging,
since it was necessary to well cover the leak, but also avoid
occluding the deep femoral artery. The endograft was
deployed meticulously at the CFA with its distal edge just
proximal to the deep femoral artery, paying attention to
avoid covering its orifice. This led, however, to incomplete
Table. Patient demographics, clinical characteristics and c
Patient no
Age/gender
(years)
Previous
operation Location
1 58/M Fem-pop L, CFA
2 74/M Fem-pop R, CFA
3 79/F Fem-tib R, SFA
4 71/M Fem-pop L, CFA
5 65/F AVG R, distal CFA
6 48/F AVG L, SFA
F, Female; M, male; Fem-pop, femoro-popliteal; Fem-tib, femorotibial; R, ri
coronary artery disease; COPD, chronic obstructive pulmonary disease; CH
AVG, arteriovenous graft.pseudoaneurysm exclusion that was further treated success-fully with coils, using the catheter that was already left in
pseudoaneurysm sac before stent-graft placement. Surgical
debridement along with pseudoaneurysm exclusion was
accomplished successfully under local anesthesia in all pa-
tients, 1-3 days after stent-graft placement (Fig 3). Addi-
tionally, in 4 patients that the arterial deficit and stent-graft
was exposed during debridement, a sartorius muscle flap
was used. No proximal and distal control was required in
any of these patients during surgery, since stent-grafts had
completely covered the arterial deficits.
No death occurred within 30 days after stent-graft
implantation. Two weeks after the procedure, 1 patient
developed pseudomembranous enterocolitis due to antibi-
otic treatment with i.v. clindamycin andwas treated accord-
ingly. The same patient also had postoperative lymphorrhea
persistent to conservative management that was finally
treated successfully with surgical exploration and lymphatic
closure.
Intraoperative cultures grew Staphylococcus aureus in all
6 (100%) patients (1 was methicillin-resistant). In 2 pa-
tients, Pseudomonas aeruginosa and Staphylococcus epider-
midis were grown additionally to Staphylococcus aureus.
Blood cultures grew Staphylococcus aureus in 2 patients. All
patients were given i.v. antibiotic therapy for 2-6 weeks,
followed by oral long-term suppressive antibiotic therapy
according to the antibiogram.
During follow-up (mean 14.1  8.2 months, range,
6-25 months) no signs of recurrent local or systemic infec-
tion were noticed in any of these patients. In addition, color
duplex ultrasound scanning showed good stent-graft pa-
tency without any signs of blood extravasation. Two pa-
tients died 8 and 10 months after the procedure due to
heart failure complications and acute myocardial infarction,
respectively. The 4 remaining patients are still being fol-
lowed.
DISCUSSION
Many systemic and local factors have been documented
to contribute in the pathogenesis of anastomotic pseudoa-
neurysms.1 Among systemic ones, it is necessary to include
arterial hypertension, anticoagulation, progression of ath-
erosclerosis in the host vessel, and the distal bed and
outflow chronic occlusion, while problems of parietal heal-
rbidities
tency time
months) Size (cm) Comorbidities
28 6.8 CAD, COPD
24 Not available CAD, CHF, COPD, CRI, AF
7 6.7 CAD, COPD, CHF
50 7.2 CAD, COPD
18 7.8 CRI, CAD, CHF
33 5.4 CRI, CAD
, left; CFA, common femoral artery; SFA, superficial femoral artery; CAD,
gestive heart failure; CRI, chronic renal insufficiency; AF, atrial fibrillation;omo
La
(
ght; Ling, infection, trauma, and mechanical compression nota-
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local causes. In our study, all 6 patients had chronically
occluded and infected grafts that probably led to anasto-
Fig 1. Clinical presentation of ruptured infected anastomotic
femoral pseudoaneurysm. A, Contained rupture. B, Rupture with
three episodes of intermittent bleeding. C, Free rupture with
seropurulent drainage.motic pseudoaneurysm formation.If left untreated, femoral anastomotic pseudoaneu-
rysms (FAPs) can be complicated by peripheral embolism
or rupture and may lead to limb loss and death.1 It is
generally accepted that these complications are unusual if
the pseudoaneurysm is asymptomatic or less than 2 cm in
diameter.3 In infectious contexts, however, rupture occurs
with an increased incidence.1 Indications for repair include
rapid expansion, infection, skin or soft tissue necrosis, distal
ischemia, pain, or rupture.7 In the present study, all 6
patients presented with contained or free rupture along
with clinical evidence of infection, thus requiring emer-
gency treatment.
Traditional management of FAPs includes open sur-
Fig 2. A, Digital subtraction angiography demonstrating an
anastomotic pseudoaneurysm at the left superficial femoral artery,
(B) treated successfully with deployment of a balloon expandable
stent-graft via retrograde popliteal approach.gery with aneurysm excision and arterial flow restoration.
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2.8%8 in uncomplicated cases, this rises up to 20% in cases
of infected pseudoaneurysms1 and is even higher in emer-
gency arterial reconstructions.3 Additionally, due to scar
tissue formation and distorted anatomy secondary to the
previously performed operation, major surgery may often
be necessary, making this treatment strategy inappropriate
for surgical high-risk patients with poor clinical status.1
Particularly in infected contexts, surgical arterial recon-
struction can be extremely cumbersome; anatomy may be
unclear, autologous grafts may be unavailable, and suture
line integrity may be compromised increasing the risk of
secondary hemorrhage.9 We have previously described the
beneficial use of the internal iliac artery as an autologous
graft for arterial reconstruction in infected contexts, as in
the case of drug addicts with infected femoral pseudoaneu-
rysms.10 However, in the present series, all 6 patients were
unfit for open surgery under general anesthesia due to
severe comorbidities, thus requiring less invasive manage-
ment.
Exclusion of the ruptured pseudoaneurysms with stent-
grafts was therefore considered an appropriate alternative
Fig 3. A, Surgical debridement and pseudoaneurysm excision
through a small inguinal incision under local anesthesia. B, Close
up view, demonstrating the arterial deficit. Note the underlying
stent-graft (arrow) and the absence of hemorrhage as a result of
complete sealing.therapeutic option for these critically ill patients. Bleedingwas promptly stopped avoiding significant operative risk
with major open surgery that would be required for prox-
imal and distal vessel control. Additionally, advancement
and deployment of covered endoprostheses was probably
more prompt than surgical exposure in the previously op-
erated fields with distorted anatomy.
Less invasive therapeutic options such as ultrasound-
guided compression (UGC)11 and ultrasound-guided
thrombin injection (UGTI)12 can be used preferentia-
lly for the elective treatment of uncomplicated femoral
pseudoaneurysms7 with small neck diameter resulting from
diagnostic and therapeutic catheterizations.13 However,
since the pseudoaneurysms of our patients were anasto-
motic with large arterial deficits and complicated with
rupture and infection, any attempt for UGC/UGTI was
judged inapplicable.
Coil embolization under either fluoroscopy or ultra-
sound scan guidance14,15 is another alternative minimally
invasive option with very good initial success rates. How-
ever, this method is frequently followed by recurrent pseu-
doaneurysm perfusion.15 To avoid such a recurrence in the
large neck infected pseudoaneurysms of our patients, coils
were not used apart from 1 case that were utilized adju-
vantly to stent-grafting. Additionally, coils were not used as
single treatment without stent-graft deployment, since they
would have to be removed later on during secondary sur-
gical debridement, thus leaving the arterial deficit uncov-
ered. In the sole patient that coils were deployed in com-
bination with a stent-graft, they were subsequently
removed along with the infected pseudoaneurysm tissue
during the second operation; however, no hemorrhage
occurred since the arterial deficit was already covered with
the stent-graft.
Despite the good results of the presented hybrid ther-
apy in this small patient series, two important concerns
should be addressed; the placement of a stent-graft (1) in
infected tissues and (2) at the CFA level. Obviously, the
success of the procedure could have been jeopardized by
the presence of infection, which was evident in all 6 pa-
tients. Indeed, placing an endoprosthesis in an infected
field is debatable, despite the reports of successful use of
stent-grafts in infected tissues as in the case of infected true and
false aneurysms,16-19 or in patients with aorto-duodenal fist-
ulas.20,21 Principles of standard management dictate that
deployment of a covered stent would be unlikely to succeed
as a treatment option for infected pseudoaneurysms, since
exclusion rather than excision of the pathology may lead to
closed-spaced infection and contamination of the newly
placed device with possible limb and life-threatening conse-
quences.6 To avoid such devastating complications, a sec-
ond operation consisted of surgical excision of the infected
pseudoaneurysm and surrounding tissues and selective sar-
torius muscle flap coverage of the CFA was performed 1-3
days after stent-graft placement. Following this hybrid ap-
proach, the infected pseudoaneurysm was finally excised
under local anesthesia avoiding major surgery for proximal
and distal vessel control. Although there are a few publica-
tions describing the use of stent-grafts for the treatment of
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edge, this is the first case series documenting a hybrid proce-
dure consisted of emergency stent-grafting and secondary
surgical pseudoaneurysm excision in the English literature.
Stent placement in the CFA is the second controversial
issue addressed in this report basically due to 4 reasons; (1)
Surgery in the CFA is generally a straight forward and safe
procedure without special demands in terms of technical
skills or surgical experience, thus reducing the attractive-
ness of a minimally invasive alternative procedure such as
stent placement. (2) There is the impression that a stented-
“jailed” CFA could no longer be used as a puncture site for
cardiovascular interventions. (3) There is a concern of
device damage by the repeated flexion and extension of the
hip joint. (4) Finally, there is the possibility of occluding the
deep femoral artery or a patent graft.
With respect to the first issue mentioned above, in our
group of patients, surgical reconstruction of the CFA was
expected to bemore challenging than usual due to previous
operations and concomitant infection. Regarding the sec-
ond concern, further vascular interventions are not pre-
cluded after CFA stenting, since the CFA can still be
punctured under fluoroscopy either above or below the
stent, thus avoiding damage to the metallic struts.24 Be-
sides, especially in our patients where there was not such a
concern, since previous arterial reconstructions at the CFA
already precluded puncture at this site even before stent
placement. Finally, with regard to the possibility of stent
damage, experimental studies in swines,25 as well as clinical
series in humans24 have concluded that stents remain struc-
turally intact in the short and mid-term period despite the
stresses of repetitive motion. The new generation self-
expanding nitinol stents are considered to behave favor-
ably, compared to the balloon-expandable in this setting,
since they offer increased resistance to repeated external
forces due to their unique structure and design. Indeed, the
nitinol self-expanding Hemobahn endograft (Gore & As-
sociates, Putzbrunn, Germany) has been utilized success-
fully at the knee joint for popliteal artery lesions without
any identified device damage.26 In this study, all stent-grafts
placed in the CFA were self-expanding, apart from 1 case. In
the latter, a balloon-expandable stent-graft was used, since
it was the only available device at the time of the emergency
repair. Furthermore, it was considered that the impaired
hip joint mobility of this patient due to ipsilateral limb
amputation would prevent stent-graft deformation or frac-
ture.
This series also highlights the role of radical surgical
debridement along with sartorius myoplasty for vascular
graft salvage in infected groin wounds. Extensive surgical
debridement was performed after stent-graft placement in
all cases; necrotic tissue was scholastically removed, and all
infectious spaces were drained and irrigated with saline. All
layers involved in the infection were desquamated. Addi-
tionally, in 4 patients sartorius myoplasty was performed to
fill the dead space and clear the infection. Indeed, the use of
a local muscle flap in conjunction with thorough wound
debridement aiming to “sterilize” the infectious foci, hasbeen successfully applied for the management of localized
prosthetic vascular graft infections especially in the groin.27
The muscle flap seems to act by increasing local tissue
oxygenation and phagocytic activity, decreasing wound
bacterial counts, augmenting the delivery of antibiotics to
the site, and eliminating dead space.27-31
The timing of surgical debridement also merits consid-
eration. As already noticed, radical surgical debridement
was performed at a second stage, 1-3 days following stent-
graft placement. As all these patients were admitted with
ruptured AFAPs, our first priority was to deploy the stent-
graft on an emergency basis so as to stop the bleeding
timely and stabilize the patients, and secondarily to treat
the infection. Surgical debridement was accomplished at a
second stage in order to minimize the risk of hemorrhage,
allowing for better sealing and stent-graft incorporation
that could be jeopardized if the debridementmanipulations
were performed at the same setting with endograft deploy-
ment. This time interval between stent-graft deployment
and debridement also allowed for more careful physical
status assessment and better patient preparation by the
anesthesiologists, which was important since these patients
might need conversion to general anesthesia during the
operation, but were in poor general condition.
It is to note that surgical debridement was performed
under local anesthesia. Although such a procedure is most
commonly carried out under general anesthesia, it was
judged that our patients, and particularly 4 of them suffer-
ing from severe chronic obstructive pulmonary disease
(COPD), were poor candidates for general anesthesia.
Consequently, it was decided to begin the operation under
local anesthesia and switch over to controlled general anes-
thesia only in case of patient intolerance. Interestingly,
repetitive infiltrations with local anesthetics at multiple
layers of the operated tissues provided adequate analgesia in
all except 1 patient, who also required light intravenous
sedation under close monitoring.
Another issue to be pointed out is that of the appropri-
ate antibiotic regimens that should be administered adjunc-
tively to the interventional therapy. All our patients were
given broad-spectrum antibiotics upon admission. Subse-
quently, antibiotic therapy was adjusted to the antibio-
grams originated from wound and blood cultures. All pa-
tients received intravenous antibiotics for 2-6 weeks,
followed by case-specific administration of oral long-term
suppressive antibiotic therapy according to the clinical and
laboratory parameters of the infection. Until the most
recent follow-up, no evidence of device (either local or
systemic) infection was noticed in any of the patients in this
series. To date, little evidence exists regarding the optimal
duration of anti-microbial treatment in these cases and
clinical practice is based mainly on arbitrary data and phy-
sicians’ personal opinion. In the literature, the recom-
mended period for periprocedural i.v. antibiotic therapy
varies from 2 to 8 weeks.32,33 Moreover, some authors
suggest life-long oral suppressive antibiotic regimen, while
others do not consider such a treatment necessary unless
there is evidence of ongoing infection.33-36 Further studies
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reach safe recommendations regarding antibiotic regimens
in such complex clinical scenarios.
As already mentioned, a limitation of the presented
approach is the possibility of occluding the deep femoral
artery or a patent graft by placing a covered endoprosthesis.
Indeed in cases that the pseudoaneurysm involves the fem-
oral bifurcation or lies in close proximity to it, placement of
a stent-graft to seal the leak may compromise blood flow in
the PFA. If the SFA is occluded, however, such a limitation
can be eliminated by deploying the stent-graft from the
CFA in the PFA, as it was done in 1 of our patients. With
respect to the possibility of occluding a patent graft, it
should be noted that these infected grafts are usually al-
ready occluded upon patient presentation. But even in case
the graft remains open, a covered endoprosthesis could, in
some instances, be placed from the donor artery to the
graft, maintaining its patency, (ie, when the graft is anasto-
mosed on the SFA where a stent-graft would not compro-
mise the PFA). Thus, although in this series all patients had
occluded grafts, theoretically, the presented procedure also
could be applied in anatomically-suitable patients with
AFAPs and still patent grafts. Further studies are necessary
to elucidate this issue.
CONCLUSION
This study evaluated the feasibility, safety, and efficacy
of a hybrid repair for ruptured infected anastomotic AFAPs
consisted of percutaneous stent-graft deployment and
second-stage surgical debridement.
Although surgery remains the treatment of choice for the
repair of ruptured infected anastomotic femoral pseudoaneu-
rysms, our preliminary results indicate that emergency pseu-
doaneurysm exclusion with a stent-graft, followed by second-
ary pseudoaneurysm excision, surgical debridement, and
long-term antimicrobial therapy is a less invasive viable
alternative. Especially for patients unfit for major surgery, it
may be the most favorable treatment option. Further stud-
ies are necessary in order to confirm these findings in larger
patient cohorts.
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